SKI Market

Indian Indices

Nifty

25,763.35 41.25
(0.16%)

Sensex

83,459.15 -519.34
( -0.62%)

Bank Nifty

58,101.45 325.10
( 0.56%)

Nifty IT

35,653.10 -59.25
( -0.17%)

Global Indices

Nasdaq

47,357.62 -226.25
(-0.48%)

Dow Jones

6,873.20 12.00
(0.17%)

Hang Seng

52,282.77 -739.19
(-1.41%)

Nikkei 225

9,706.66 -10.59
(-0.11%)

Forex

USD-INR

88.54 -0.03
(-0.03%)

EUR-INR

102.14 -0.53
(-0.52%)

GBP-INR

116.39 -0.30
(-0.26%)

JPY-INR

0.57 0.00
(-0.30%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Ipca Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524494

INE571A01038

271.6399623

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

IPCALAB

36.6

33232.72

EPS(TTM)

Face Value()

Div & Yield %

35.79

0.31

Back

authum investment & infrastructure ltd

Simplex Papers reports standalone net loss of Rs 0.03 crore in the June 2025 quarter

Aug 06,2025

Net Loss of Simplex Papers reported to Rs 0.03 crore in the quarter ended June 2025 as against net loss of Rs 0.04 crore during the previous quarter ended June 2024. There were no Sales reported in the quarter ended June 2025 and during the previous quarter ended June 2024.

25,763.35 41.25 (0.16%)

83,459.15 -519.34 ( -0.62%)

58,101.45 325.10 ( 0.56%)

35,653.10 -59.25 ( -0.17%)

47,357.62 -226.25 (-0.48%)

6,873.20 12.00 (0.17%)

52,282.77 -739.19 (-1.41%)

9,706.66 -10.59 (-0.11%)

88.54 -0.03 (-0.03%)

102.14 -0.53 (-0.52%)

116.39 -0.30 (-0.26%)

0.57 0.00 (-0.30%)